We’re excited to announce the formation of a new anesthesia group in Riverdale, GA, located just 10 minutes from the Atlanta Airport. We’re seeking dedicated CRNAs to join our collaborative care team, which will include 4 full-time CRNAs and 2 anesthesiologists managing 4 operating rooms. This is a 25% independent practice and doing own blocks! […]
Read MoreAUTHORS: Zhang, Haopeng PhD, MD et al Anesthesia & Analgesia ():10.1213/ANE.0000000000007514, April 17, 2025. BACKGROUND: Minimum alveolar concentration (MAC) is used as the standard measure of potency for volatile anesthetic agents. However, there is a lack of effective and quantitative indicator of the combined potency of multiple coadministered inhalation and intravenous anesthetics. We hypothesized that an […]
Read MoreAUTHORS: Yu, Yao MD et al Anesthesia & Analgesia ():10.1213/ANE.0000000000007584, May 23, 2025. BACKGROUND: Malignant hyperthermia (MH) is a life-threatening pharmacogenetic disorder triggered by certain anesthetics, characterized by muscle rigidity, elevated body temperature, and hypermetabolic crisis. This condition is primarily associated with genetic mutations in ryanodine receptor 1 (RYR1), which encodes the pivotal calcium release channel […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review Amid a growing anesthesia workforce shortage, stakeholders across the industry are pondering how to build a more sustainable and effective pipeline of providers. Seven anesthesia leaders connected with Becker’s to discuss their most urgent priorities for combating the shortage, from workforce collaboration to expansion of training programs. Question: What are the […]
Read MoreAuthor: Alicia Ault Medscape Anesthesiology The US Food and Drug Administration (FDA) is urging manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses needed due to the rise of high-potency opioids like fentanyl. The agency published its proposal in the Federal Register in late December. The move comes on the heels of […]
Read More